Even six months isn't long enough for safety in CNS, but three months is absurd. Many of the drugs that are currently approved in this area have longer term side effects. Can anyone with more knowledge of the biochemistry side of things explain why Bryostatin would not have the long term side effect issues of other IGF drugs?
Market Data 
Markets 
AI
